13.12.2013 15:08:53

FMC Corp. To Sell Peroxygens Business To One Equity Partners For $200 Mln

(RTTNews) - Diversified chemicals maker FMC Corp. (FMC) said Friday that it has signed a definitive agreement to sell its Peroxygens business to affiliates of One Equity Partners, the private investment arm of J.P. Morgan Chase & Co. (JPM). The transaction valued at approximately $200 million.

It is expected to close in the first quarter of 2014, subject to customary regulatory approvals and closing conditions.

In April, FMC simplified its organizational structure to focus on three core business segments that better reflect the markets where the company participates and leads, and where it expects to grow in the future. FMC Peroxygens, although a successful business, is not a strategic fit with the company's growth platforms.

Analysen zu JPMorgan Chase & Co.mehr Analysen

16.01.25 JPMorgan Chase Outperform RBC Capital Markets
16.01.25 JPMorgan Chase Halten DZ BANK
16.01.25 JPMorgan Chase Buy UBS AG
15.01.25 JPMorgan Chase Outperform RBC Capital Markets
02.12.24 JPMorgan Chase Hold Deutsche Bank AG
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

FMC Corp. 53,60 -0,96% FMC Corp.
JPMorgan Chase & Co. 257,80 0,12% JPMorgan Chase & Co.